OnCall

The rise of genomic sequencing and use of novel agents in the new standard of cancer care has created new challenges in recognizing and managing toxicities. In this episode, we are joined by Dr. Ian Olver, medical oncologist, bioethicist, researcher and current Professorial Research Fellow in the School of Psychology at the University of Adelaide, to discuss strategies and tools to support communi...

The average oncologist would need 29 hours a day to keep up with the advances in cancer care. There are new treatments, policies, drugs, toxicities, trials—and a shortage of oncologists and nurses.  In this episode, we are joined by Dr. Fred Ashbury, co-founder and chief scientific officer at Viecure, to highlight the key areas where A.I. significantly improves your ability to treat patients effec...

The evolution of cancer care is advancing so quickly, it’s nearly impossible to keep up. Genetic sequencing has radically improved our ability to get the right drug to the right patient—improving outcomes for both patients and practices. But policy is unclear, lab testing is interpreted differently, and funding is available—but how do you get it? In this episode, we are joined by Dr. Howard McLeod...

Precision medicine is refocusing which clinical trials are possible, but we still have a ~5% participation rate and non-diverse patient demographic. Community oncology is the doorway to changing the face of clinical trials in the era of precision medicine. In this podcast, we talk about why, how and what’s in it for your practice to facilitate clinical trials in the community setting. Learn more a...

Listen to a discussion between Jonathan Abbas, MD, and Mark Levis, MD, PhD. Please listen to additional safety information for TIBSOVO® (ivosidenib tablets) at the end of this presentation. Please visit TibsovoPro.com to review the Full Prescribing Information , including BOXED WARNING.

In this episode, we met with Dr. John Marshall, a medical oncologist, Georgetown University professor and frequent guest speaker at ION Solutions events, and his wife, Liza Marshall, to discuss their book, “Off Our Chests: A Candid Tour Through the World of Cancer”. To learn more or purchase a copy of the book, visit OffOurChestsBook.com . If you have any questions for today’s guests, or have a to...

In this episode Natasha Clinton, Director of Medical Affairs for IntrinsiQ Specialty Solutions, and Nicole Chambers, Senior Director of Corporate Services for ION Solutions, discuss the advancements in liquid and tissue biopsy testing as well as the improvements our partners are making in the precision medicine space. If you have any questions for today’s guests or a topic you would like to learn...

In this episode, a part of our Precision Medicine series, Susan Weidner, Senior VP of IntrinsiQ  Analytics, and Natasha Clinton, Director of Medical Affairs for IntrinsiQ Specialty Solutions, discuss the overall strategy for ION’s precision medicine program - from the creation of the Precision Medicine Advisory Panel to where we are headed in the future. If you have any questions for today’s guest...

In this extended episode, Brian Ansay, President of ION and IPN Solutions, sat down with Joe Baffone, Co-Founder and CEO of Annexus Health, to discuss our partnership and the exciting opportunities available to our members. Reach out to your ION or IPN Solutions sales rep or visit the Annexus Health website to learn more. We want to make sure you are getting the most out of our content, so if you...

This is the first episode in what will be our ongoing Precision Medicine series in which we will touch on all aspects of this expanding field, particularly in its relation to community oncology practices. Nicole Chambers, Senior Director of Corporate Services at ION Solutions, and Carol Riley, Practice Manager at St. Louis Cancer Care, will discuss the creation of the Precision Medicine Center, IO...